# Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

> **NCT06846853** · PHASE4 · RECRUITING · sponsor: **UConn Health** · enrollment: 10 (estimated)

## Conditions studied

- Contrast Enhanced Images vs. Non-contrast Images
- Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images

## Interventions

- **DRUG:** Gadopiclenol
- **DRUG:** Gadobutrol (Gadavist, BAY86-4875)

## Key facts

- **NCT ID:** NCT06846853
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-25
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06846853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06846853, "Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06846853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*